Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Does magnetic resonance spectroscopy identify patients with minimal hepatic encephalopathy?

Ciećko-Michalska I, Dziedzic T, Banyś R, Senderecka M, Binder M, Wyczesany M, Szewczyk J, Wójcik J, Słowik A, Mach T.

Neurol Neurochir Pol. 2012 Sep-Oct;46(5):436-42.

PMID:
23161187
2.

Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.

Geissler A, Lock G, Fründ R, Held P, Hollerbach S, Andus T, Schölmerich J, Feuerbach S, Holstege A.

Hepatology. 1997 Jan;25(1):48-54.

PMID:
8985263
3.

MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.

Tarasów E, Panasiuk A, Siergiejczyk L, Orzechowska-Bobkiewicz A, Lewszuk A, Walecki J, Prokopowicz D.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2149-53.

PMID:
14696484
4.

Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.

Hassan EA, Abd El-Rehim AS, Seifeldein GS, Shehata GA.

Arab J Gastroenterol. 2014 Sep-Dec;15(3-4):108-13. doi: 10.1016/j.ajg.2014.09.003. Epub 2014 Nov 11.

PMID:
25459346
5.

Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.

Meng LP, Chen YC, Li YH, Zhu JS, Ye JL.

Eur J Radiol. 2015 Oct;84(10):2019-23. doi: 10.1016/j.ejrad.2015.06.027. Epub 2015 Jun 30.

PMID:
26170124
6.

1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy.

Miese F, Kircheis G, Wittsack HJ, Wenserski F, Hemker J, Mödder U, Häussinger D, Cohnen M.

AJNR Am J Neuroradiol. 2006 May;27(5):1019-26.

7.

Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.

Mechtcheriakov S, Schocke M, Kugener A, Graziadei IW, Mattedi M, Hinterhuber H, Vogel W, Marksteiner J.

Neuroradiology. 2005 Jan;47(1):27-34. Epub 2005 Jan 18.

PMID:
15655660
8.

[Myoinositol trends in HMRS brain spectrum of patients with hepatic encephalopathy].

Herman-Sucharska I, Grzybek M, Grochowska A, Karcz P, Urbanik A.

Przegl Lek. 2010;67(4):247-50. Polish.

PMID:
20687354
9.

Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.

Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, Fuchs M, Bouneva I, Puri P, Luketic V, Sanyal AJ, Gilles H, Heuman DM, Bajaj JS.

J Hepatol. 2013 Sep;59(3):467-73. doi: 10.1016/j.jhep.2013.04.023. Epub 2013 May 7.

10.

Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.

Razek AA, Abdalla A, Ezzat A, Megahed A, Barakat T.

Neuroradiology. 2014 Oct;56(10):885-91. doi: 10.1007/s00234-014-1409-0. Epub 2014 Jul 25.

PMID:
25060166
11.
12.

Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.

Rovira A, Grivé E, Pedraza S, Rovira A, Alonso J.

AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1137-42.

13.

Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.

Lee JH, Seo DW, Lee YS, Kim ST, Mun CW, Lim TH, Min YI, Suh DJ.

Am J Gastroenterol. 1999 Aug;94(8):2206-13.

PMID:
10445551
14.

Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.

Guevara M, Baccaro ME, Gómez-Ansón B, Frisoni G, Testa C, Torre A, Molinuevo JL, Rami L, Pereira G, Sotil EU, Córdoba J, Arroyo V, Ginès P.

J Hepatol. 2011 Sep;55(3):564-73. doi: 10.1016/j.jhep.2010.12.008. Epub 2010 Dec 14.

PMID:
21163310
15.

MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.

Naegele T, Grodd W, Viebahn R, Seeger U, Klose U, Seitz D, Kaiser S, Mader I, Mayer J, Lauchart W, Gregor M, Voigt K.

Radiology. 2000 Sep;216(3):683-91.

PMID:
10966695
16.

Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.

Bokemeyer M, Ding XQ, Goldbecker A, Raab P, Heeren M, Arvanitis D, Tillmann HL, Lanfermann H, Weissenborn K.

Gut. 2011 Mar;60(3):370-7. doi: 10.1136/gut.2010.217976. Epub 2010 Oct 6.

PMID:
20926642
17.

Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo.

Singhal A, Nagarajan R, Hinkin CH, Kumar R, Sayre J, Elderkin-Thompson V, Huda A, Gupta RK, Han SH, Thomas MA.

J Magn Reson Imaging. 2010 Jul;32(1):35-43. doi: 10.1002/jmri.22216.

PMID:
20578008
18.

In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.

Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK.

Liver Int. 2008 Sep;28(8):1095-103. doi: 10.1111/j.1478-3231.2007.01648.x. Epub 2008 Feb 8.

PMID:
18266634
19.

Proton magnetic resonance spectroscopy of late-life major depressive disorder.

Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.

Psychiatry Res. 2009 Jun 30;172(3):210-4. doi: 10.1016/j.pscychresns.2009.01.003. Epub 2009 Mar 20.

PMID:
19303260
20.

Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.

Weissenborn K, Ahl B, Fischer-Wasels D, van den Hoff J, Hecker H, Burchert W, Köstler H.

Gut. 2007 Dec;56(12):1736-42. Epub 2007 Jul 27.

Supplemental Content

Support Center